Metraipolis › archive › dc_d02b29dfbeda

Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42201048
DOI: 10.3390/medsci14020256
License (as archived): solo-consultazione
Archived: 2026-11-02T07:43:32.215Z
SHA-256 of the archived text: 5433a97c7759b3ab29937edfe9ba6c989dff10f853f094b62e9a5f9336774749
Stable URL of this page: https://metraipolis.com/documento/dc_d02b29dfbeda

How to cite

Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048 — Europe PMC (en), https://europepmc.org/article/MED/42201048 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d02b29dfbeda (Metraipolis archive dc_d02b29dfbeda, sha256 5433a97c7759b3ab29937edfe9ba6c989dff10f853f094b62e9a5f9336774749)

BibTeX

@misc{dcd02b29dfbeda,
  title = {Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42201048},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d02b29dfbeda; sha256 5433a97c7759b3ab29937edfe9ba6c989dff10f853f094b62e9a5f9336774749},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201048. Agents can read the archived copy with the MCP tool read_document.